| ORIGINAL ARTICLE |
|
| Year : 2018 | Volume
: 20
| Issue : 5 | Page : 438-441 |
|
|
Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases
Rui Chen1, Lei Wang1, Xia Sheng1, Shu-Guang Piao1, Xin-Wen Nian1, Xin Cheng1, Tie Zhou1, Hui-Zhen Li1, Ya-Wei Liu2, Guang-Hua Chen1, Chun-Lei Zhang1, De-Pei Kong1, Guang-An Xiao1, Xin Lu1, Zhen-Yu Jia1, Zhi-Yong Liu1, Ying-Hao Sun1
1 Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China
2 Medical College of Chinese People's Liberation Army and Chinese People's Liberation Army General Hospital, Beijing 100853, China
Correspondence Address:
Dr. Ying-Hao Sun
Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China
Dr. Zhi-Yong Liu
Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/aja.aja_76_17
|
|
|
We summarized our experience in transurethral seminal vesiculoscopy (TSV) for recurrent hemospermia by introducing surgical techniques, intraoperative findings, and treatment outcomes. TSV was performed in 419 patients with an initial diagnosis of persistent hemospermia at Shanghai Changhai Hospital (Shanghai, China) from May 2007 to November 2015. TSV was successfully performed in 381 cases (90.9%). Hemospermia was alleviated or disappeared in 324 (85.0%) patients by 3 months after surgery. Common intraoperative manifestations were bleeding, obstruction or stenosis, mucosal lesions, and calculus. Endoscopic presentation of the ejaculatory duct orifice and the verumontanum was categorized into four types, including 8 (1.9%), 32 (7.6%), 341 (81.4%), and 38 (9.1%) cases in Types A, B, C, and D, respectively. TSV is an effective and safe procedure in the management of seminal tract disorders. This study may help other surgeons to become familiar with and improve this procedure. However, further multicentric clinical trials are warranted to validate these findings.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
